Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 5—May 2024
Research

Epidemiologic Survey of Crimean-Congo Hemorrhagic Fever Virus in Suids, Spain

Mario Frías, Kerstin Fischer, Sabrina Castro-Scholten, Caroline Bost, David Cano-Terriza, Maria Ángeles Risalde, Pelayo Acevedo, Saúl Jiménez-Ruiz, Balal Sadeghi, Martin H. Groschup, Javier Caballero-GómezComments to Author , and Ignacio García-Bocanegra
Author affiliations: Universidad de Córdoba, Córdoba, Spain (M. Frías, S. Castro-Scholten, D. Cano-Terriza, M.Á. Risalde, S. Jiménez-Ruiz,, J. Caballero-Gómez, I. García-Bocanegra); CIBERINFEC, ISCIII, Madrid, Spain (M. Frías, D. Cano-Terriza, M.Á. Risalde, J. Caballero-Gómez, I. García-Bocanegra); Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany (K. Fischer, C. Bost, B. Sadeghi, M.H. Groschup); Universidad de Castilla La Mancha y Consejo Superior de Investigaciones Científicas (CSIC), Ciudad Real, Spain (P. Acevedo)

Main Article

Table 1

Distribution and seroprevalence of Crimean-Congo hemorrhagic fever in wild boars and extensively raised Iberian pigs, Spain

Variable Wild boars
 Iberian pigs
No. positive/no. analyzed Seroprevalence, % (95% CI) p value No. positive/no. analyzed Seroprevalence, % (95% CI) p value
Season
2015–16 10/20 50.0 (28.8–71.1) 0.8885 NA NA
2016–17 16/45 35.5 (22.6–50.2) NA NA
2017–18 27/66 40.9 (29.5–53.0) 1/126 0.8 (0–2.3) 0.0123
2018–19 26/63 41.2 (29.6–53.6) 6/77 7.8 (1.8–13.8)
2019–20 20/52 38.4 (26.0–52.1) 0/48 0 (0–0)
2020–21
 7/21
 33.3 (15.9–55.1)
NA
 NA
Province
Badajoz 7/32 21.9 (7.6–36.2) 0.0119 0/79 0 (0–0.3) <0.001
Cáceres 20/45 44.4 (30.5–59.1) 6/46 13.0 (3.3–22.8)
Córdoba 51/100 51.0 (41.2–60.8) 1/126 0.8 (0–2.3)
Jaén 13/44 29.5 (17.5–44.1) NA NA
Sevilla
 15/46
 32.6 (19.1–46.2)
NA
 NA
Age
Yearling 9/45 20.0 (0–26.1) <0.001 NA NA NA
Subadult 23/70 32.9 (21–38.6) NA NA
Adult
 72/147
 49.0 (41.0–57.0)
NA
 NA
Sex
M 41/124 33.1 (25.2–41.7) 0.0435 NA NA NA
F 64/139 46.0 (37.8–54.3) NA NA

*NA, not applicable.

Main Article

Page created: April 16, 2024
Page updated: April 23, 2024
Page reviewed: April 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external